Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Langley

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Chemical Information and Modeling|May 21, 2010
MORPH: a new tool for ligand designBrett R Beno, David R Langley
Nature Reviews. Drug Discovery|January 19, 2022
PROTAC targeted protein degraders: the past is prologueMiklós Békés, David R Langley, Craig M Crews
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Electrostatic interaction of pi-acidic amides with hydrogen-bond acceptorsYi Li, Lawrence B Snyder, David R Langley
The Journal of Chemical Physics|December 24, 2011
Communication: Quantum polarized fluctuating charge model: a practical method to include ligand polarizability in biomolecular simulationsS Roy Kimura, Ramkumar Rajamani, David R Langley
Proteins|January 5, 2008
Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approachS Roy Kimura, Andrew J Tebben, David R Langley
Plos One|February 20, 2010
Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavirAnn W Walsh, David R Langley, Richard J Colonno, et al.
Journal of Chemical Information and Modeling|June 26, 2009
E-novo: an automated workflow for efficient structure-based lead optimizationBradley C Pearce, David R Langley, Jia Kang, et al.
ACS Omega|September 5, 2022
Mutagenic Activation of Glutathione Peroxidase-4: Approaches toward Rational Design of Allosteric DrugsChunyue Ma, Daniel J Chung, Dylan Abramson, et al.
Organic Letters|October 16, 2009
Nucleophilic capture of the imino-quinone methide type intermediates generated from 2-aminothiazol-5-yl carbinolsMark G Saulnier, Marco Dodier, David B Frennesson, et al.
Biochemistry|November 11, 2008
The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitorsDavid R Langley, Himadri K Samanta, Zeyu Lin, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Chemical Information and Modeling|May 21, 2010
MORPH: a new tool for ligand designBrett R Beno, David R Langley
Nature Reviews. Drug Discovery|January 19, 2022
PROTAC targeted protein degraders: the past is prologueMiklós Békés, David R Langley, Craig M Crews
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Electrostatic interaction of pi-acidic amides with hydrogen-bond acceptorsYi Li, Lawrence B Snyder, David R Langley
The Journal of Chemical Physics|December 24, 2011
Communication: Quantum polarized fluctuating charge model: a practical method to include ligand polarizability in biomolecular simulationsS Roy Kimura, Ramkumar Rajamani, David R Langley
Proteins|January 5, 2008
Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approachS Roy Kimura, Andrew J Tebben, David R Langley
Plos One|February 20, 2010
Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavirAnn W Walsh, David R Langley, Richard J Colonno, et al.
Journal of Chemical Information and Modeling|June 26, 2009
E-novo: an automated workflow for efficient structure-based lead optimizationBradley C Pearce, David R Langley, Jia Kang, et al.
ACS Omega|September 5, 2022
Mutagenic Activation of Glutathione Peroxidase-4: Approaches toward Rational Design of Allosteric DrugsChunyue Ma, Daniel J Chung, Dylan Abramson, et al.
Organic Letters|October 16, 2009
Nucleophilic capture of the imino-quinone methide type intermediates generated from 2-aminothiazol-5-yl carbinolsMark G Saulnier, Marco Dodier, David B Frennesson, et al.
Biochemistry|November 11, 2008
The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitorsDavid R Langley, Himadri K Samanta, Zeyu Lin, et al.
Pageof 6